Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
43.38
-0.43 (-0.98%)
At close: Jun 27, 2025, 4:00 PM
43.40
+0.02 (0.05%)
After-hours: Jun 27, 2025, 6:31 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.53 billion as of June 27, 2025. Its market cap has increased by 2.30% in one year.
Market Cap
2.53B
Enterprise Value
1.86B
1-Year Change
2.30%
Ranking
Category
Stock Price
$43.38
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.53B, an increase of 212.96%. That is a compound annual growth rate of 79.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 2.56B | -0.80% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.30B |
| Johnson & Johnson | 364.78B |
| AbbVie | 329.17B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.58B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.17B |
| AstraZeneca | 216.45B |